DataMEDS AI, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- TRxADE HEALTH, Inc. (NASDAQ: MEDS) operates an online pharmaceutical marketplace that connects independent pharmacies with pharmaceutical distributors, manufacturers, and other suppliers across the United States. The company provides a suite of digital services and products, including its proprietary TRxADE platform for real-time pricing, inventory management, and order fulfillment; Tru-Pak for drop-shipping and packaging services; and TRxADE Prime, a subscription-based analytics tool offering market intelligence, competitive bidding, and supply chain optimization for independent pharmacies. Founded in 2018 and headquartered in Boca Raton, Florida, TRxADE HEALTH focuses on serving independent retail pharmacies, wholesalers, and healthcare providers in the U.S. pharmaceutical distribution sector, with no international operations publicly noted. In recent developments within the last year, the company has pursued strategic expansions in its digital health offerings, including enhancements to its AI-driven procurement tools and partnerships aimed at improving drug pricing transparency amid ongoing supply chain challenges. No major acquisitions, funding rounds, or rebranding have been announced as of late 2025.
Company News
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
Head to Head Analysis: CorVel (NASDAQ:CRVL) versus Wellgistics Health (NASDAQ:MEDS)
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI
DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
TRxADE Health, Inc. Announces Special Cash Dividend
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q